Bydureon BCise Injector

The once weekly GLP-1 Receptor Agonist, Bydureon, is a dual chambered pen that requires mixing and assembly that was challenging for some patients.

Download our FREE Updated Insulin PocketCard

To improve the patient experience, a new extended release pre-filled delivery device, Bydureon BCise – has been approved by the FDA. for adults with type 2 diabetes. The new autoinjector features a simpler mixing process, a hidden needle, and a viewing window for users to confirm that they’ve received the medication.

Features of Bydureon BCise (rhymes with “precise”) is expected to launch in early 2018.

• Easier mixing: To prep the BCise pen for injection, the user simply has to shake it for 15 seconds. By comparison, the older dual-chambered pen instructed users to tap it “80 times or more.”

• Pre-attached needle: With the dual-chambered pen, users had to screw on the needle cap. Bydureon BCise comes with a hidden needle.

• Easier injection: To administer Bydureon BCise, users are directed to push the pen against the skin and hold for 15 seconds, removing the hassle of needle insertion and holding down the plunger.

To get the new autoinjector, healthcare professionals must write a prescription specifically for Bydureon BCise. AstraZeneca has not specified what the price of Bydureon BCise beyond suggesting that it will be comparable to the dual-chambered pen pricing.

---

Medication Update Webinar – Feb 19, 2018 11:30 to 1pm (PST)